Stem cell therapy ameliorates bladder dysfunction in an animal model of Parkinson disease.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Journal of Urology

• Publication date

  2012-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.juro.2011.11.079PMID 22341818
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Bladder Dysfunction and Parkinsonism: Current Pathophysiological Understanding and Management Strategies

  2011cited by this paper
• Development of bladder dysfunction in a rat model of dopaminergic brain lesion

  2011cited by this paper
• Direct Intrathecal Implantation of Mesenchymal Stromal Cells Leads to Enhanced Neuroprotection via an NFκB-Mediated Increase in Interleukin-6 Production

  2010cited by this paper
• Mesenchymal stem cell‐secreted superoxide dismutase promotes cerebellar neuronal survival

  2010cited by this paper
• Mitochondria: a therapeutic target in neurodegeneration.

  2010cited by this paper
• Multiple neurogenic and neurorescue effects of human mesenchymal stem cell after transplantation in an experimental model of Parkinson's disease.

  2010cited by this paper
• Human Mesenchymal Stem Cells Efficiently Manage Oxidative Stress

  2010cited by this paper
• Protective Effect of Human Amniotic Fluid Stem Cells in an Immunodeficient Mouse Model of Acute Tubular Necrosis

  2010cited by this paper
• Restorative approaches in Parkinson's Disease: which cell type wins the race?

  2010cited by this paper
• Effects of IL-6 secreted from astrocytes on the survival of dopaminergic neurons in lipopolysaccharide-induced inflammation.

  2009cited by this paper
• Human Amniotic Fluid Stem Cells Do Not Differentiate Into Dopamine Neurons In Vitro or After Transplantation In Vivo

  2009cited by this paper
• Bladder and bowel dysfunction in Parkinson’s disease

  2008cited by this paper
• Absolute requirement of GDNF for adult catecholaminergic neuron survival

  2008cited by this paper
• Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease

  2008cited by this paper
• Isolation of amniotic stem cell lines with potential for therapy

  2007cited by this paper
• Pluripotency of mesenchymal stem cells derived from adult marrow

  2007cited by this paper
• Regeneration of the central nervous system using endogenous repair mechanisms

  2007cited by this paper
• Time‐course of nigrostriatal damage, basal ganglia metabolic changes and behavioural alterations following intrastriatal injection of 6‐hydroxydopamine in the rat: new clues from an old model

  2007cited by this paper
• Neurotrophic factors for the treatment of Parkinson's disease.

  2007cited by this paper
• Human mesenchymal stem cell subpopulations express a variety of neuro-regulatory molecules and promote neuronal cell survival and neuritogenesis.

  2006cited by this paper
• Increased survival and migration of engrafted mesenchymal bone marrow stem cells in 6-hydroxydopamine-lesioned rodents.

  2006cited by this paper
• Molecular pathophysiology of Parkinson's disease.

  2005cited by this paper
• Histological, behavioural and neurochemical evaluation of medial forebrain bundle and striatal 6-OHDA lesions as rat models of Parkinson's disease.

  2005cited by this paper
• Parkinson's Disease Mechanisms and Models

  2003cited by this paper
• Astrocyte-targeted expression of IL-6 protects the CNS against a focal brain injury.

  2003cited by this paper
• Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease

  2002cited by this paper
• Pluripotency of mesenchymal stem cells derived from adult marrow

  2002cited by this paper
• Immunomodulatory effects of pretransplant donor blood transfusion on T-cell-independent xenoreactive immunity.

  2000cited by this paper
• A stable system for the high-titer production of multiply attenuated lentiviral vectors.

  2000cited by this paper
• Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat.

  1998cited by this paper
• The Rat Brain in Stereotaxic Coordinates

  1983cited by this paper

• Tracking of autologous adipose-derived mesenchymal stromal/stem cells after intravenous administration: a pilot study in a dog with induced acute bladder injury

  2025cites this paper
• Leveraging animal models to understand non-motor symptoms of Parkinson's disease.

  2025cites this paper
• Amniotic Fluid as a Potential Source of Extracellular Vesicles With Anti-inflammatory and Regenerative Properties

  2024cites this paper
• Body fluid-derived stem cells — an untapped stem cell source in genitourinary regeneration

  2023influential citation
• The Use of Stem Cells as a Potential Treatment Method for Selected Neurodegenerative Diseases: Review

  2023cites this paper
• Photobiomodulation Therapy and Cell Therapy Improved Parkinson's Diseases by Neuro-regeneration and Tremor Inhibition.

  2022cites this paper
• Therapeutic Approaches to Non-Motor Symptoms of Parkinson's Disease: A Current Update on Preclinical Evidence

  2022cites this paper
• Considerations for the clinical use of stem cells in genitourinary regenerative medicine

  2021cites this paper
• Regenerative Stem Cell Therapy for Neurodegenerative Diseases: An Overview

  2021cites this paper
• Animal Model for Lower Urinary Tract Dysfunction in Parkinson’s Disease

  2020cites this paper
• Stem Cell Therapy for Neurogenic Bladder Dysfunction in Rodent Models: A Systematic Review

  2020cites this paper
• Other New Developments: Use of Stem Cells and Gene Therapy

  2019cites this paper
• Mesenchymal Stromal Cell Therapies for Neurodegenerative Diseases.

  2019cites this paper
• Therapeutic Potential of Amniotic Fluid Derived Mesenchymal Stem Cells Based on their Differentiation Capacity and Immunomodulatory Properties.

  2019influential citation
• Functionalized cardiovascular stents: Cardiovascular stents incorporated with stem cells

  2018cites this paper
• Urological dysfunction in synucleinopathies: epidemiology, pathophysiology and management

  2018cites this paper
• Non-motor features of Parkinson disease

  2017cites this paper
• Bladder Transplantation of Amniotic Fluid Stem Cell may Ameliorate Bladder Dysfunction After Focal Cerebral Ischemia in Rat

  2017cites this paper
• Nonmotor Symptoms in Experimental Models of Parkinson's Disease.

  2017cites this paper
• Prevalence and treatment of LUTS in patients with Parkinson disease or multiple system atrophy

  2017cites this paper
• Immunomodulatory effects of stem cells: Therapeutic option for neurodegenerative disorders.

  2017cites this paper
• New Frontiers of Basic Science Research in Neurogenic Lower Urinary Tract Dysfunction

  2017cites this paper
• Comparative study on characterization and wound healing potential of goat (Capra hircus) mesenchymal stem cells derived from fetal origin amniotic fluid and adult bone marrow.

  2017cites this paper
• Use of sodium butyrate combined with bone marrow mesenchymal stem cells improves acontractile detrusor in a cryoinjury rat model

  2016cites this paper
• Mesenchymal Stem Cells from Wharton's Jelly and Amniotic Fluid.

  2016cites this paper
• Chemical conversion of mouse fibroblasts into functional dopaminergic neurons.

  2016cites this paper
• Amniotic Fluid-Derived Stem Cells (AFSC) and Their Application in Cell Therapy and Tissue Engineering

  2015cites this paper
• Bone Marrow Mesenchymal Stem Cell Therapy for Voiding Dysfunction

  2015cites this paper
• Cell-Based Therapies in Lower Urinary Tract Disorders

  2015cites this paper
• Lower urinary tract dysfunction in patients with parkinsonism and other neurodegenerative disorders.

  2015cites this paper
• Clinical neurorestorative progress in Parkinson's disease

  2015cites this paper
• Stem Cells Therapy

  2014cites this paper
• Effects of allogeneic bone marrow derived mesenchymal stromal cell therapy on voiding function in a rat model of Parkinson disease.

  2014cites this paper
• The Use of ADSCs as a Treatment for Chronic Stroke

  2014cites this paper
• Bioengineering of the Lower Urinary Tract

  2014cites this paper
• Transplantation of mesenchymal stem cells exerts anti-apoptotic effects in adult rats after spinal cord ischemia-reperfusion injury.

  2014cites this paper
• Animal Models of Lower Urinary Tract Dysfunction

  2013cites this paper
• The Pharmacology of Regenerative Medicine

  2013cites this paper
• Therapeutic potential of amniotic fluid-derived cells for treating the injured nervous system.

  2013cites this paper
• Transplantation of human mesenchymal stem cells loaded on collagen scaffolds for the treatment of traumatic brain injury in rats.

  2013cites this paper
• Human amniotic fluid stem cells as an attractive tool for clinical applications.

  2013cites this paper
• Nanofiber for cardiovascular tissue engineering

  2013cites this paper
• Targeted Delivery of Nano-Therapeutics for Major Disorders of the Central Nervous System

  2013cites this paper
• Stem cell therapy in neurodegenerative diseases

  2012cites this paper
• Applications of Amniotic Membrane and Fluid in Stem Cell Biology and Regenerative Medicine

  2012cites this paper
• Clonal Populations of Amniotic Cells by Dilution and Direct Plating: Evidence for Hidden Diversity

  2012cites this paper
• Editorial Amniotic Stem Cells: Potential in Regenerative Medicine

  2012cites this paper
• Amniotic Stem Cells: Potential in Regenerative Medicine

  2012cites this paper
• Bone marrow-derived mesenchymal stem cells increase dopamine synthesis in the injured striatum

  2012cites this paper
• Direct Intrathecal Implantation of Mesenchymal Stromal Cells Leads to Enhanced Neuroprotection via an NFκB-Mediated Increase in Interleukin-6 Production

  2010cites this paper